Algorhythm director granted stock and options
Algorhythm Holdings, Inc. director Harvey Judkowitz received equity compensation in the form of stock and options.
Rhea-AI Filing Summary
Algorhythm Holdings, Inc. director Harvey Judkowitz received equity compensation in the form of stock and options. He was granted a restricted stock award covering 19,532 shares of common stock and a non-qualified stock option for 19,532 shares at an exercise price of $1.28 per share.
Both the restricted stock award and the option were granted under the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan. Each award vests in equal quarterly installments over one year from the grant date, meaning the director earns the rights to these shares gradually as service-based conditions are met.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 39,064 shares
Grant/Award
2 txns
Insider
JUDKOWITZ HARVEY
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 19,532 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 19,532 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 19,532 contracts (Direct);
Common Stock — 19,532 shares (Direct)
Footnotes (3)
- F1. The reported transaction involved the Reporting Person's receipt of a restricted stock award for 19,532 shares of the Issuer's common stock (the "RSA"). The RSA was granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan. The RSA represents a contingent right to receive 19,532 shares of the Issuer's common stock. The RSA vests in equal quarterly installments over a period of one year from the date of grant.
- F2. The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 19,532 shares of the Issuer's common stock. The option was granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan.
- F3. The shares subject to the non-qualified stock option vest and become exercisable in equal quarterly installments over a period of one (1) year from the date of grant.
Key Figures
Restricted stock award size: 19,532 shares
Stock option grant size: 19,532 shares
Option exercise price: $1.28 per share
+2 more
5 metrics
Restricted stock award size
19,532 shares
Common stock RSA granted to director Harvey Judkowitz
Stock option grant size
19,532 shares
Non-qualified stock option on common stock
Option exercise price
$1.28 per share
Conversion or exercise price of non-qualified stock option
Option expiration date
November 20, 2035
Expiration of non-qualified stock option term
Shares held after RSA
19,532 shares
Total common stock held directly following restricted stock award
Key Terms
restricted stock award, non-qualified stock option, 2022 Equity Incentive Plan, vests in equal quarterly installments, +1 more
5 terms
restricted stock award financial
"The reported transaction involved the Reporting Person's receipt of a restricted stock award for 19,532 shares"
A restricted stock award is company shares given to an employee or executive that cannot be sold or fully owned until certain conditions—like staying with the company for a set time or hitting performance targets—are met. Think of it as a gift that only becomes yours after you fulfill specific obligations; for investors, these awards matter because they can increase the total shares outstanding when they vest, reveal how management is being paid and motivated, and create potential selling pressure when restrictions lift.
non-qualified stock option financial
"The reported transaction involved the Reporting Person's receipt of a non-qualified stock option to purchase 19,532 shares"
A non-qualified stock option (NSO) is a contract that lets an employee or service provider buy company shares at a fixed price for a set period, like a voucher to purchase stock later at today’s price. It matters to investors because exercising NSOs creates ordinary income for the holder and can increase share count, affecting a company’s earnings and ownership mix; think of it as a future sale that can dilute existing shareholders and has immediate tax consequences for the recipient.
2022 Equity Incentive Plan financial
"The RSA was granted pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan"
vests in equal quarterly installments financial
"The RSA vests in equal quarterly installments over a period of one year"
contingent right financial
"The RSA represents a contingent right to receive 19,532 shares"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What equity awards did Algorhythm Holdings (RIME) director Harvey Judkowitz receive?
He received a restricted stock award for 19,532 common shares and a non-qualified stock option for 19,532 common shares. Both awards were granted as compensation under the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan, rather than through open-market purchases.
What is the exercise price and term of Harvey Judkowitz’s stock options at Algorhythm Holdings (RIME)?
The non-qualified stock option allows him to purchase 19,532 shares of Algorhythm Holdings common stock at an exercise price of $1.28 per share. The option expires on November 20, 2035, giving a long window to exercise once vested.
How do the new Algorhythm Holdings (RIME) restricted stock units for Harvey Judkowitz vest?
The restricted stock award for 19,532 shares vests in equal quarterly installments over one year from the grant date. This means portions of the award convert into shares periodically as continued service requirements are met, aligning compensation with ongoing board service.
How do Harvey Judkowitz’s new stock options at Algorhythm Holdings (RIME) vest?
The non-qualified stock option for 19,532 shares vests and becomes exercisable in equal quarterly installments over one year from the grant date. As each installment vests, a portion of the option becomes available for potential exercise at the fixed exercise price.
AI-generated analysis. How Rhea-AI works. Not financial advice.
